Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CANC NYSEARCA:ILDR NYSEARCA:PRAY NASDAQ:ZAP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANCTema Oncology ETF$25.78+2.8%$24.57$20.10▼$30.11$74.76M1.1111,834 shs9,824 shsILDRFirst Trust Innovation Leaders ETF$29.77+1.2%$27.24$19.74▼$30.63$74.43M1.0918,278 shs34,939 shsPRAYFIS Biblically Responsible Risk Managed ETF$30.95+0.5%$29.78$25.13▼$31.04$71.80M0.86,736 shs2,213 shsZAPGlobal X U.S. Electrification ETF$26.85+1.0%$26.07$22.16▼$26.99$72.50MN/A43,587 shs33,432 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANCTema Oncology ETF+2.79%+2.06%+1.62%+20.30%-6.36%ILDRFirst Trust Innovation Leaders ETF+1.19%+2.23%+7.55%+35.13%+24.66%PRAYFIS Biblically Responsible Risk Managed ETF+0.45%+0.68%+3.89%+16.14%+11.25%ZAPGlobal X U.S. Electrification ETF+0.98%+0.71%+3.27%+14.01%+2,684,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCANCTema Oncology ETFN/AN/AN/AN/AN/AN/AN/AN/AILDRFirst Trust Innovation Leaders ETFN/AN/AN/AN/AN/AN/AN/AN/APRAYFIS Biblically Responsible Risk Managed ETFN/AN/AN/AN/AN/AN/AN/AN/AZAPGlobal X U.S. Electrification ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCANCTema Oncology ETF 2.81Moderate Buy$25.78N/AILDRFirst Trust Innovation Leaders ETF 2.81Moderate Buy$29.77N/APRAYFIS Biblically Responsible Risk Managed ETF 2.72Moderate Buy$30.95N/AZAPGlobal X U.S. Electrification ETF 2.55Moderate Buy$26.85N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCANCTema Oncology ETFN/AN/AN/AN/AN/AN/AILDRFirst Trust Innovation Leaders ETFN/AN/AN/AN/AN/AN/APRAYFIS Biblically Responsible Risk Managed ETFN/AN/AN/AN/AN/AN/AZAPGlobal X U.S. Electrification ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCANCTema Oncology ETFN/AN/A20.39∞N/AN/AN/AN/AN/AILDRFirst Trust Innovation Leaders ETFN/AN/A39.35∞N/AN/AN/AN/AN/APRAYFIS Biblically Responsible Risk Managed ETFN/A-$0.02N/A∞N/AN/AN/AN/AN/AZAPGlobal X U.S. Electrification ETFN/A-$0.10N/A∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCANCTema Oncology ETF$0.722.79%N/AN/AN/AILDRFirst Trust Innovation Leaders ETF$0.030.10%N/AN/AN/APRAYFIS Biblically Responsible Risk Managed ETF$0.210.68%N/AN/A N/AZAPGlobal X U.S. Electrification ETF$0.281.04%N/AN/A N/ALatest ILDR, CANC, ZAP, and PRAY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/2/2025ZAPGlobal X U.S. Electrification ETFQuarterly$0.14472.15%7/3/20257/3/20257/11/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCANCTema Oncology ETFN/AILDRFirst Trust Innovation Leaders ETFN/APRAYFIS Biblically Responsible Risk Managed ETFN/AZAPGlobal X U.S. Electrification ETFN/AInsider OwnershipCompanyInsider OwnershipCANCTema Oncology ETFN/AILDRFirst Trust Innovation Leaders ETFN/APRAYFIS Biblically Responsible Risk Managed ETFN/AZAPGlobal X U.S. Electrification ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCANCTema Oncology ETFN/A2.90 millionN/ANot OptionableILDRFirst Trust Innovation Leaders ETFN/A2.50 millionN/ANot OptionablePRAYFIS Biblically Responsible Risk Managed ETFN/A2.32 millionN/ANot OptionableZAPGlobal X U.S. Electrification ETFN/A2.70 millionN/AN/AILDR, CANC, ZAP, and PRAY HeadlinesRecent News About These CompaniesGlobal X Funds - US Electrification EtfJune 1, 2025 | seekingalpha.comGlobal X U.S. Electrification ETF (ZAP)February 4, 2025 | finance.yahoo.comGlobal X U.S. Electrification ETFFebruary 1, 2025 | seekingalpha.comMedia Sentiment Over TimeILDR, CANC, ZAP, and PRAY Company DescriptionsTema Oncology ETF NASDAQ:CANC$25.78 +0.70 (+2.79%) As of 07/9/2025 03:32 PM EasternThe Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.First Trust Innovation Leaders ETF NYSEARCA:ILDR$29.77 +0.35 (+1.19%) As of 07/9/2025 04:10 PM EasternThe First Trust Innovation Leaders ETF (ILDR) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that seeks capital appreciation by targeting global companies believed to benefit from scientific and technological innovation. ILDR was launched on May 25, 2021 and is managed by First Trust.FIS Biblically Responsible Risk Managed ETF NYSEARCA:PRAY$30.95 +0.14 (+0.45%) Closing price 07/9/2025 04:10 PM EasternExtended Trading$30.92 -0.03 (-0.10%) As of 07/9/2025 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The FIS Biblically Responsible Risk Managed ETF (PRAY) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund that employs a risk-managed approach to invest in stocks from around the world that are perceived as biblically responsible investments. PRAY was launched on Feb 8, 2022 and is managed by Faith Investor Services.Global X U.S. Electrification ETF NASDAQ:ZAP$26.85 +0.26 (+0.98%) As of 07/9/2025 03:54 PM EasternThe Global X U.S. Electrification ETF (ZAP) is an exchange-traded fund that is based on the Global X US Electrification index. The fund tracks market-cap selected and weighted index of US listed companies in developed markets involved in the industry of electrification. This includes companies involved in conventional and alternative electricity, and smart grid technologies. ZAP was launched on Dec 17, 2024 and is issued by Global X. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Why Marvell Could Be the Smartest AI Bet Under $80 Autodesk Stock Ready to Rip? Q3 May Be the Turning Point Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
